Volume 47, Issue 5 pp. 709-710
COMMENTARY

Comment on: ‘Detecting drug-drug interactions that increase the incidence of long QT syndrome using a spontaneous reporting system’ by Matsuo et al

Yoshihiro Noguchi PhD

Corresponding Author

Yoshihiro Noguchi PhD

Laboratory of Clinical Pharmacy, Gifu Pharmaceutical University, Gifu, Japan

Correspondence

Yoshihiro Noguchi and Hitomi Teramachi, Laboratory of Clinical Pharmacy, Gifu Pharmaceutical University, Gifu, Japan.

Emails: [email protected] (YN); [email protected] (HT)

Search for more papers by this author
Tomoya Tachi PhD

Tomoya Tachi PhD

Laboratory of Clinical Pharmacy, Gifu Pharmaceutical University, Gifu, Japan

Search for more papers by this author
Hitomi Teramachi PhD

Corresponding Author

Hitomi Teramachi PhD

Laboratory of Clinical Pharmacy, Gifu Pharmaceutical University, Gifu, Japan

Correspondence

Yoshihiro Noguchi and Hitomi Teramachi, Laboratory of Clinical Pharmacy, Gifu Pharmaceutical University, Gifu, Japan.

Emails: [email protected] (YN); [email protected] (HT)

Search for more papers by this author
First published: 28 December 2021

Funding information

This re-analysis was supported by JSPS KAKENHI Grant Number 19K20731.

No abstract is available for this article.

CONFLICT OF INTEREST

All authors declare that there are no competing interests.

DATA AVAILABILITY STATEMENT

In this study, the Ω shrinkage measure scores and 95% CIs were calculated from the raw data in Table 3 of the article by Matsuo et al.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.